AKANTIOR ® (polihexanida) es el primer y único fármaco aprobado para el tratamiento de la queratitis por acanthamoeba CATANIA, Italia, 26 de agosto de 2024 /PRNewswire/ — SIFI, una empresa internacional líder en oftalmología, ha anunciado hoy que la Comisión Europea ha aprobado AKANTIOR®…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.